United States News Todas as matérias

AudioCodes (NASDAQ:AUDC) reported second-quarter 2026 revenues of $63 million, representing a 3.1% year-over-year increase.

Zebra Technologies (NASDAQ:ZBRA) reported second-quarter net sales of $1.557 billion, up 20.4%, while net income reached $233 million.

Palantir Technologies (NASDAQ:PLTR) reported Q2 revenue of $1.94 billion, up 93%, as its U.S. business generated $1.57 billion.

Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q2 revenue of $3.33 billion, up 12%, as its CF and newer treatments generated growth.

Boeing (NYSE:BA) received FAA certification for the 737-7, clearing the smallest 737 MAX variant for commercial service.

Broadcom (NASDAQ:AVGO) lost its court bid to suspend an EU antitrust request for U.S. legal documents related to VMware.

Carrier Global (NYSE:CARR) completed the sale of NORESCO to OPTERRA Energy Services, transferring the business to an LS Power subsidiary.

Alexander’s (NYSE:ALX) reported Q2 net income of $155.4 million, or $30.24 per diluted share, following a major property-sale gain.

Giftify (NASDAQ:GIFT) reported Q2 gross billings of $45.5 million, up 26.2%, while net sales increased 4.0% to $21.7 million.

Douglas Dynamics (NYSE:PLOW) announced its financial results for the second quarter of 2026, reporting record net sales of $214.6 million.

TG Therapeutics (NASDAQ:TGTX) reported Q2 global revenue of $240.3 million as U.S. BRIUMVI sales increased 64% to $227.7 million.

AstraZeneca (NASDAQ:AZN) has reportedly engaged in early-stage negotiations regarding a potential merger with Bristol Myers Squibb (NYSE:BMY).

Sportradar (NASDAQ:SRAD) reported Q2 revenue of €378 million, up 19%, while adjusted EBITDA increased 19% to €76 million.

Ocular Therapeutix (NASDAQ:OCUL) reported Q2 revenue of $13.5 million and plans a Q4 AXPAXLI filing after FDA alignment.

Krystal Biotech (NASDAQ:KRYS) reported Q2 VYJUVEK revenue of $119.2 million, up 24%, and net income of $54.8 million.

Hess Midstream (NYSE:HESM) reported Q2 revenue of $399 million, net income of $173.7 million and adjusted free cash flow of $231.6 million.

Compugen (NASDAQ:CGEN) reported Q2 revenue of $2.6 million and said its $125.3 million cash position could fund operations into 2029.

Tyson Foods (NYSE:TSN) announced its financial results for the fiscal third quarter of 2026, reporting flat sales of $13.87 billion.

Lindblad Expeditions Holdings (NASDAQ:LIND) reported Q2 tour revenue of $199.2 million, up 19% year over year.

Marriott International (NASDAQ:MAR) announced its second-quarter 2026 financial results, reporting an adjusted net income of $844 million.

Indivior Pharmaceuticals (NASDAQ:INDV) reported Q2 revenue of $343 million, up 14%, and announced an all-stock Supernus merger.

Brookfield Asset Management (NYSE:BAM) completed its Oaktree acquisition, combining both credit platforms into a $365 billion global franchise.

Supernus Pharmaceuticals (NASDAQ:SUPN) reported Q2 revenue of $219.1 million, up 32%, and announced an all-stock merger with Indivior Pharmaceuticals (NASDAQ:INDV).